Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 3 | Yi StevenDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $37K 4,000 sh | Apr 1, 2026 traded Mar 30, 2026 | |
Pena Fernando AustinDirector, President |
Open-market sale · 10b5-1 plan |
| SELL |
| $31K 1,666 sh |
| Apr 1, 2026 traded Mar 31, 2026 |
| 50 | Weaver Robert S.EVP, Government Relations | Open-market sale | SELL | $399K 1,872 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 50 | Morgan RachelEVP General Counsel | Open-market sale | SELL | $668K 3,127 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 47 | Lamattina John LDirector | Open-market sale | SELL | $434K 2,161 sh | Mar 31, 2026 traded Mar 6, 2026 |
| 44 | Degner DennisChief Executive Officer & Pres | Open-market sale | SELL | $693K 15.0K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 40 | Mark AlfordRSelf | Partial sale | SELL | $1,001 – $15K | Mar 31, 2026 traded Mar 16, 2026 |
| 40 | Preston Tracy MEVP, CLO & Corporate Secretary | Open-market sale | SELL | $49K 2,736 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 39 | Bron OlivierCEO, Bloomingdale's | Open-market sale | SELL | $54K 3,051 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 39 | Weitman GarySee Remarks | Open-market sale | SELL | $214K 1,005 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 36 | McDowell Erin WSVP & General Counsel | Open-market sale | SELL | $396K 8,250 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 35 | Szabo ShandellDirector | Open-market sale | SELL | $375K 11.7K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 35 | Manor SagitCFO | Open-market sale | SELL | $69K 1,252 sh | Mar 31, 2026 traded Mar 31, 2026 |
| 33 | Huang Michael F.Sr. VP of Clinical Development | Open-market sale | SELL | $128K 4,256 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 33 | Manning MeredithChief Commercial Officer | Open-market sale | SELL | $146K 4,864 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 32 | Furman Carly LisanneCEO NAYX North America | Open-market sale | SELL | $17K 313 sh | Mar 31, 2026 traded Mar 31, 2026 |
| 32 | Tepper OrenCRO | Open-market sale | SELL | $3,991 74 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 30 | Garagic DenisCHIEF TECHNOLOGY OFFICER | Open-market sale | SELL | $84K 15.1K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 29 | Manning MeredithChief Commercial Officer | Open-market sale | SELL | $65K 2,100 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 29 | Huang Michael F.Sr. VP of Clinical Development | Open-market sale | SELL | $57K 1,838 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 29 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $356K 44.0K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 27 | Thatcher TrevorCHIEF FINANCIAL OFFICER | Open-market sale | SELL | $17K 3,030 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 27 | Sonne StephenCHIEF LEGAL OFFICER | Open-market sale | SELL | $19K 3,471 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 26 | Manning MeredithChief Commercial Officer | Open-market sale | SELL | $18K 558 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 26 | Huang Michael F.Sr. VP of Clinical Development | Open-market sale | SELL | $15K 488 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 26 | Lentell EricChief Legal & Strategy Officer | Open-market sale · 10b5-1 plan | SELL | $268K 50.0K sh | Mar 31, 2026 traded Mar 26, 2026 |
| 25 | Mark AlfordRSelf | Partial sale | SELL | $1,001 – $15K | Mar 31, 2026 traded Mar 16, 2026 |
| 25 | Mark AlfordRSelf | Partial sale | SELL | $1,001 – $15K | Mar 31, 2026 traded Mar 16, 2026 |
| 25 | Tirman MatthewPresident | Open-market sale | SELL | $49K 9,499 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 24 | Ugwumba Chidozie10% Owner | Open-market sale | SELL | $332K 68.0K sh | Mar 31, 2026 traded Mar 31, 2026 |
| 21 | Lozinski Jeffrey William10% Owner | Open-market sale | SELL | $3,000 100.0K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 20 | Lentell EricChief Legal & Strategy Officer | Open-market sale · 10b5-1 plan | SELL | $265K 50.0K sh | Mar 31, 2026 traded Mar 27, 2026 |
| 20 | Mark AlfordRSelf | sold @ $493.42/share SPY – 8.318 shares sold @ $670.024/share DIA – 8.426 shares sold @ $470.985/share SPYD – 57.383 shares sold @ $46.04/share AMZN – 25 shares sold @ $209.40/share AAPL – 20.313 shares sold @ $253.45/share QQQ – 4.105 shares sold @ $601.68/share PYPL – 9.021 shares sold @ $47.735/share DIA - State Street SPDR Dow Jones Indust Avg ETF Trust NYSEARCA: DIA Partial sale | SELL | $1,001 – $15K | Mar 31, 2026 traded Mar 16, 2026 |
| 20 | Mark AlfordRSelf | Partial sale | SELL | $1,001 – $15K | Mar 31, 2026 traded Mar 16, 2026 |
| 20 | Mark AlfordRSelf | Partial sale | SELL | $1,001 – $15K | Mar 31, 2026 traded Mar 16, 2026 |
| 20 | Mark AlfordRSelf | sold @ $493.42/share SPY – 8.318 shares sold @ $670.024/share DIA – 8.426 shares sold @ $470.985/share SPYD – 57.383 shares sold @ $46.04/share AMZN – 25 shares sold @ $209.40/share AAPL – 20.313 shares sold @ $253.45/share QQQ – 4.105 shares sold @ $601.68/share PYPL – 9.021 shares sold @ $47.735/share Invesco QQQ Partial sale | SELL | $1,001 – $15K | Mar 31, 2026 traded Mar 16, 2026 |
| 20 | Mark AlfordRSelf | Partial sale | SELL | $1,001 – $15K | Mar 31, 2026 traded Mar 16, 2026 |
| 20 | Mark AlfordRSelf | Partial sale | SELL | $1,001 – $15K | Mar 31, 2026 traded Mar 16, 2026 |
| 19 | Rubinstein JuliePresident and COO | Open-market sale · 10b5-1 plan | SELL | $241K 19.1K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 19 | Rubinstein JuliePresident and COO | Open-market sale · 10b5-1 plan | SELL | $220K 16.3K sh | Mar 31, 2026 traded Mar 27, 2026 |